Innovative UNC-based Public-Private HIV Investigative Group Secures $20m & Continues its Leading ‘Induce & Reduce’ Strategy

University of North Carolina (UNC) Chapel Hill researchers and local industry scientists secured $20 million in the from of a research contract targeting a cure for HIV. The deal was executed between ViiV Healthcare and UNC at Chapel Hill to renew the unique,...

How Close Are We to a Workable HIV Vaccine?

Where are we at with the elusive HIV vaccine? Still a ways to go, it would appear, reports SciDevNet. The only answer is an HIV vaccine and developing one has been a challenge. Cecilia Rosen of SciDevNet reports that although we have achieved significant advancements...

Pin It on Pinterest